Search Orphan Drug Designations and Approvals
-
Generic Name: | fenretinide |
---|---|
Date Designated: | 09/04/2013 |
Orphan Designation: | Treatment of peripheral T-cell lymphoma |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 12/13/2021 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
CerRx, Inc. Reese Technology Center 9801 Reese Blvd, Suite 104 Lubbock, Texas 79416 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-